In glioma genomics, TERT promoter mutations are frequently found in over 70% of primary GBM and oligodendrogliomas, and less frequently in oligoastrocytomas and WHO grade II and III diffuse astrocytomas [18, 19, 21]. Here, TERT is linked to central nervous system cancer.